Pharming Group N.V.
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to developing and commercializing innovative treatments for patients with rare, debilitating, and life-threatening diseases. The company's portfolio focuses on protein replacement therapies and precision medicines designed to address significant unmet medical needs. By concentrating on both development and commercialization, Pharming aims to provide transformative therapies to underserved patient populations worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-31 08:23 |
Earnings Release
Pharming Group reports second quarter and first half 2025 financial results and…
|
Dutch | 669.6 KB | ||
| 2025-07-31 08:23 |
Earnings Release
Pharming Group reports second quarter and first half 2025 financial results and…
|
English | 589.3 KB | ||
| 2025-07-31 07:16 |
Earnings Release
Pharming Group N.V., Halfjaarlijkse financiële verslaggeving
|
English | 589.3 KB | ||
| 2025-06-24 07:35 |
Regulatory News Service
Pharming Group to host webcast on findings of a new study published in Cell adv…
|
Dutch | 290.6 KB | ||
| 2025-06-24 07:35 |
Regulatory News Service
Pharming Group to host webcast on findings of a new study published in Cell adv…
|
English | 260.5 KB | ||
| 2025-06-12 07:44 |
Post-Annual General Meeting Information
Pharming Group reports on results of the 2025 Annual General Meeting of Shareho…
|
Dutch | 182.9 KB | ||
| 2025-06-12 07:44 |
Post-Annual General Meeting Information
Pharming Group reports on results of the 2025 Annual General Meeting of Shareho…
|
English | 176.9 KB | ||
| 2025-05-01 06:28 |
Pre-Annual General Meeting Information
Pharming Group announces the 2025 Annual General Meeting of Shareholders and th…
|
English | 182.9 KB | ||
| 2025-04-23 09:44 |
Environmental & Social Information
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as…
|
English | 296.9 KB | ||
| 2025-04-03 07:26 |
Annual Report (ESEF)
Pharming Group N.V., Jaarlijkse financiële verslaggeving
|
English | 25.3 MB | ||
| 2025-03-04 15:29 |
Post-Annual General Meeting Information
Pharming Group reports on results of the 2025 Extraordinary General Meeting of …
|
Dutch | 224.7 KB | ||
| 2025-03-04 15:29 |
Board/Management Information
Pharming Group reports on results of the 2025 Extraordinary General Meeting of …
|
English | 224.4 KB | ||
| 2025-02-21 07:38 |
M&A Activity
Pharming Technologies B.V. vergroot haar belang in Abliva AB (publ) naar 92,70 …
|
Dutch | 254.4 KB | ||
| 2025-02-21 07:38 |
M&A Activity
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70…
|
English | 284.0 KB | ||
| 2025-02-10 07:36 |
M&A Activity
Pharming Technologies B.V. declares unconditional and completes the recommended…
|
Dutch | 272.1 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
